tiprankstipranks
Trending News
More News >
Crescent Capital BDC (CCAP)
NASDAQ:CCAP

Crescent Capital BDC (CCAP) AI Stock Analysis

Compare
374 Followers

Top Page

CCAP

Crescent Capital BDC

(NASDAQ:CCAP)

Select Model
Select Model
Select Model
Neutral 58 (OpenAI - 5.2)
Rating:58Neutral
Price Target:
$13.50
â–²(4.90% Upside)
Action:ReiteratedDate:03/10/26
The score is held to the mid-range by financial statement comparability concerns in the latest annual data and weak technical trend signals (price below major moving averages with negative MACD). These are partly offset by supportive valuation (high dividend yield, moderate P/E) and a generally constructive earnings update with dividend coverage and meaningful spillover income, despite NAV/nonaccrual pressure and rate-driven headwinds.
Positive Factors
Portfolio credit quality
A portfolio concentrated in first‑lien, sponsor‑backed loans with moderate LTVs and covenants materially lowers long‑run loss severity and supports recoveries. The strong risk-rating mix (86% rated 1–2) indicates durable underwriting discipline that should sustain income through credit cycles and preserve distributable earnings.
Extended maturities & liquidity
Extending the debt maturity profile and holding sizable undrawn capacity reduces refinancing and liquidity risk over the medium term. This structural improvement gives management flexibility to originate, manage covenant or market stress, and smooth funding costs, supporting stable net investment income and capital management.
Scale and active origination platform
High origination activity and platform scale produce a durable pipeline and allow Crescent to act as lead/agent, capturing fees and better economics. Consistent deployment and attractive realized spreads on new platforms underpin recurring interest and fee income, helping replenish and diversify the portfolio over multiple quarters.
Negative Factors
Rising nonaccruals & NAV pressure
An uptick in nonaccruals and a quarter‑over‑quarter NAV decline reflect pockets of credit deterioration that can erode future cash returns. Persistent or widening nonaccruals increase realized loss risk and reduce distributable income, pressuring dividend sustainability and requiring longer remediation or workout timelines.
Yield compression from lower rates
With many assets tied to floating rates, a structurally lower reference rate environment compresses yields and net interest margins. Even with slightly lower funding costs, persistent spread pressure reduces NII over months, making it harder to cover base dividends absent higher deployment yields or fee changes.
Dividend/fee structure uncertainty
A formal review of dividend and fee policies signals management expects durable earnings pressure and may alter cash return mechanics. Potential fee or dividend changes introduce structural uncertainty about future shareholder income and could reflect a need to rebase payout to match lower long‑term NII.

Crescent Capital BDC (CCAP) vs. SPDR S&P 500 ETF (SPY)

Crescent Capital BDC Business Overview & Revenue Model

Company DescriptionCrescent Capital BDC, Inc. is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.
How the Company Makes MoneyCrescent Capital BDC generates revenue primarily through interest income from its investments in debt securities, as well as through dividend income from equity investments in its portfolio companies. The company earns interest on loans provided to middle-market companies, which typically offer higher yields than traditional fixed-income investments. Additionally, CCAP may charge fees for structuring and managing loans, providing further revenue streams. The company also benefits from capital appreciation in its equity investments, which can enhance overall returns. Strategic partnerships and relationships with financial institutions and investment firms can facilitate access to new investment opportunities and enhance its market positioning, contributing to its overall earnings.

Crescent Capital BDC Earnings Call Summary

Earnings Call Date:Feb 25, 2026
(Q4-2025)
|
% Change Since: |
Next Earnings Date:May 13, 2026
Earnings Call Sentiment Positive
The call presented a balanced but constructive view: management highlighted durable portfolio fundamentals (diversified, predominantly first-lien, sponsor-backed, strong interest coverage), proactive balance-sheet actions (extended debt maturities, ample liquidity), meaningful spillover income and continued origination activity. Headwinds included modest NAV decline, a small uptick in nonaccruals (partially remediated in January), and pressure on yields and NII from lower base rates. Management is proactively reviewing dividend and fee frameworks to bolster long-term earnings durability, and expects to provide a fuller update next quarter.
Q4-2025 Updates
Positive Updates
Net Investment Income and Dividend Coverage
Reported net investment income (NII) of $0.45 per share in Q4 2025 vs $0.46 prior quarter (≈-2.2%). NII covered the base dividend by 107%; Board declared quarterly cash dividend of $0.42 per share for Q1 2026.
Strong Spillover Income
Spillover income approximately $1.16 per share, nearly 3x the base dividend, providing meaningful supplemental support to earnings during the rate transition.
Portfolio Size and Diversification
Investment portfolio at fair value ≈ $1.6 billion across 184 companies; average investment ≈0.6% of portfolio. 91% first lien, 99% sponsor-backed, weighted average LTV at origination ≈40%, and 71% of portfolio includes covenants.
Deployment and Deal Economics
Gross deployment in Q4 totaled $71 million (5 new platform investments totaling $29 million; $42 million incremental investments). New platform investments carried a weighted average spread of ~490 bps, with Crescent acting as lead or agent.
Yield and Coverage Trends
Weighted average yield on income-producing securities at cost fell by 40 bps Q/Q to 10% (driven by lower base rates), while weighted average interest coverage improved to 2.2x, indicating underlying portfolio earnings resiliency.
Capital Structure and Liquidity Enhancements
Proactively priced $185 million of senior unsecured notes (delayed draw); first $135 million closed in Feb, final $50 million to fund in May. Pro forma, >90% of committed debt now matures 2028 or later, extending maturity profile.
Prudent Leverage and Liquidity
Net debt-to-equity ~1.20x (quarter-end debt-to-equity 1.25x, or 1.2x net of cash), inside target range (1.1x–1.3x). Available liquidity includes ~$242 million undrawn capacity and >$30 million cash.
Active Origination Platform
Crescent private credit platform committed >$6.5 billion in 2025 (including >$1.7 billion in Q4). Existing portfolio served as an active origination channel with add-ons representing over half of transactions.
Realized Gains and Nonaccrual Remediation
Recorded a realized gain from sale of a previously nonaccrual investment (MTS) sold above cost in Q4. Subsequent January actions (one restructure, one sale) materially reduced pro forma nonaccruals.
Sector Expertise—Software & Services
Software & services represent ~20% of the portfolio; long track record (15+ years) with disciplined, cash-flow driven underwriting (first lien only, no ARR loans), and portfolio showing revenue/EBITDA growth and deleveraging.
Negative Updates
NAV Decline Quarter-over-Quarter
Net asset value per share declined to $19.10 as of Dec 31, 2025 from $19.28 as of Sept 30, 2025 (≈-0.93%), driven by net unrealized depreciation tied to certain portfolio companies.
NII Slight Decline and Rate Headwinds
Net investment income decreased from $0.46 to $0.45 Q/Q (≈-2.2%), and management acknowledged forward base rate expectations as a headwind for BDC earnings power in a lower-rate environment.
Increase in Nonaccruals (Quarter-End)
Nonaccruals rose during Q4: as a percentage of debt investments at cost increased from 3.3% to 4.1% (+0.8 ppt) and at fair value from 1.6% to 2.0% (+0.4 ppt), driven by two new nonaccruals (Generate and Transportation Insight).
Unrealized Losses Concentrated in Specific Names & Sectors
Largest unrealized loss drivers were two investments placed on nonaccrual (one deterioration in company outlook and Transportation Insight tied to third-party logistics weakness), contributing to quarterly NAV pressure.
Suppressed Yield Environment
Weighted average stated interest rate on total borrowings declined to 5.83% from 5.99% (-16 bps) and portfolio yields declined 40 bps, reflecting lower reference rates that compress floating-rate asset yields.
No Supplemental Dividend for Q4
The supplemental dividend measurement test (a two-quarter NAV lookback) resulted in no supplemental dividend being paid for Q4 earnings, reducing total distributed payout for the period versus prior expectations.
Competitive & Challenging Market Dynamics
Management noted intensified competition in private credit with tighter spreads and evolving deal structures, subdued exit activity (backlog of portfolio companies), and ongoing uncertainty that could pressure future spreads and yields.
Uncertainty Around Potential Dividend/Fee Changes
Management and the Board are reviewing options (including fee structure and base dividend level) to address durable earnings in a lower-rate environment, signaling potential future changes and near-term uncertainty.
Company Guidance
Management guided that Q4 net investment income was $0.45 per share (down from $0.46 Q3) and covered the base dividend by 107%; the Board declared a $0.42/share Q1 2026 cash dividend (payable April 15, record March 31). NAV was $19.10 at 12/31 (vs. $19.28 at 9/30), total investments at fair value were ~$1.6B across 184 companies (avg position ~0.6%), with 91% first‑lien, 99% sponsor‑backed, a ~40% weighted avg LTV at origination, 71% of loans with covenants and a weighted avg portfolio risk rating of 2.1 (86% rated 1–2). Activity and credit metrics: Crescent’s private credit platform committed >$6.5B in 2025 (>$1.7B in Q4); Q4 gross deployment was $71M (5 new platforms $29M at a weighted avg spread ~490 bps; $42M add‑ons), Q4 exits/sales/repayments ~ $78M (net realizations ≈ $7M); yield at cost fell 40 bps QoQ to 10%, interest coverage improved to 2.2x, and nonaccruals rose to 4.1% of cost / 2.0% of fair value (pro forma after January actions ~3.2% cost / 1.4% FV). Capitalization and liquidity: total net assets $706M, NAV $19.10, quarter‑end debt‑to‑equity 1.25x (1.20x net of cash) within the 1.1–1.3x target, weighted avg stated borrowing rate 5.83% (down from 5.99%), $185M of senior unsecured notes priced (first $135M funded; $50M funds in May), >90% of committed debt now matures in 2028 or later, $242M undrawn capacity and >$30M cash; spillover income is ~ $1.16/share (~3x the base dividend). Management and the Board are reviewing fee structure and base dividend level to shore up long‑term earnings durability and will provide a more fulsome update in May.

Crescent Capital BDC Financial Statement Overview

Summary
Fundamentals are decent but uneven: income statement and cash flow show generally strong profitability and mostly positive cash generation in 2021–2024, while leverage is meaningful. The biggest drag is the major discontinuity/inconsistency in the 2025 annual income and balance sheet figures versus prior years, reducing confidence in trend quality and comparability.
Income Statement
62
Positive
Revenue has been volatile over the period (sharp decline in 2022, strong rebound in 2023, modest decline in 2024, and ~13% growth in 2025), but profitability has generally been strong in most years, with healthy profit margins in 2021–2024. A key concern is the 2025 annual net income figure and margin reading, which appears outsized versus revenue and inconsistent with prior years, reducing confidence in trend quality and comparability. Overall, earnings power looks solid, but reported volatility and data consistency issues temper the score.
Balance Sheet
55
Neutral
Leverage is meaningful, with debt-to-equity around ~0.8–1.2 in 2020–2024, which is not unusual for the business model but increases sensitivity to credit cycles and funding conditions. Return on equity improved from low levels in 2022 and was healthier in 2023–2024. The 2025 annual balance sheet shows zero debt and extremely large equity/assets versus prior years, which is a major discontinuity and creates uncertainty around true leverage and capitalization. Net: acceptable balance sheet in 2020–2024, but 2025 comparability risk holds back the score.
Cash Flow
58
Neutral
Operating cash flow and free cash flow were positive in most years and improved meaningfully from 2021 through 2024, with operating cash flow covering net income strongly in 2022–2024 (coverage above ~1.6x). However, 2020 posted negative operating and free cash flow, highlighting potential variability in cash generation. 2025 shows positive cash flow and very high free cash flow growth, but given other 2025 inconsistencies, the strength is less conclusive. Overall: generally supportive cash generation with some historical volatility.
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue156.19M142.44M147.33M52.10M101.10M
Gross Profit121.85M83.50M92.46M23.17M84.93M
EBITDA103.11M74.74M84.11M16.50M87.28M
Net Income34.51M73.65M83.84M15.54M83.63M
Balance Sheet
Total Assets1.62T1.66B1.63B1.30B1.32B
Cash, Cash Equivalents and Short-Term Investments31.50B10.13M7.78M6.40M10.07M
Total Debt873.76M875.84M844.78M654.46M631.04M
Total Liabilities916.10B915.64M884.78M690.34M665.52M
Stockholders Equity706.04B740.64M742.59M612.54M652.28M
Cash Flow
Free Cash Flow74.72M82.75M61.81M58.38M28.45M
Operating Cash Flow74.72M82.75M61.81M58.38M28.45M
Investing Cash Flow27.95M-23.85M30.48M-30.43M-186.11M
Financing Cash Flow-82.54M-43.47M-84.99M-34.41M166.32M

Crescent Capital BDC Technical Analysis

Technical Analysis Sentiment
Negative
Last Price12.87
Price Trends
50DMA
14.05
Negative
100DMA
14.14
Negative
200DMA
14.23
Negative
Market Momentum
MACD
-0.31
Positive
RSI
36.75
Neutral
STOCH
49.35
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CCAP, the sentiment is Negative. The current price of 12.87 is below the 20-day moving average (MA) of 13.48, below the 50-day MA of 14.05, and below the 200-day MA of 14.23, indicating a bearish trend. The MACD of -0.31 indicates Positive momentum. The RSI at 36.75 is Neutral, neither overbought nor oversold. The STOCH value of 49.35 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for CCAP.

Crescent Capital BDC Risk Analysis

Crescent Capital BDC disclosed 71 risk factors in its most recent earnings report. Crescent Capital BDC reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Crescent Capital BDC Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
63
Neutral
$402.52M3.443.34%15.77%-11.01%-65.56%
61
Neutral
$536.80M2.1024.70%11.02%-45.46%134.73%
59
Neutral
$404.64M19.717.50%9.31%41.12%-40.68%
59
Neutral
$314.73M10.645.42%16.61%-3.09%200.66%
58
Neutral
$475.20M15.330.02%13.20%-20.18%-61.90%
53
Neutral
$320.46M-5.23-12.44%21.13%-91.81%78.46%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
CCAP
Crescent Capital BDC
12.87
-2.84
-18.08%
GLAD
Gladstone Capital
17.91
-7.15
-28.54%
GAIN
Gladstone Investment
13.48
1.39
11.48%
PNNT
Pennantpark Investment
4.82
-1.36
-22.02%
TCPC
BlackRock TCP Capital
3.80
-3.23
-45.95%
CION
CION Investment Corp
7.79
-2.68
-25.58%

Crescent Capital BDC Corporate Events

Business Operations and StrategyPrivate Placements and Financing
Crescent Capital BDC Issues New Senior Unsecured Notes
Positive
Mar 9, 2026

Crescent Capital BDC issued $67.5 million of Tranche A senior unsecured notes due February 13, 2029 and $67.5 million of Tranche B senior unsecured notes due February 13, 2031 on February 13, 2026, carrying fixed coupon rates of 5.87% and 6.20%, respectively. The company also plans to issue $50 million of Tranche C senior unsecured notes due May 22, 2029 on May 22, 2026, subject to customary closing conditions, further diversifying its long-term funding.

In conjunction with the February 13, 2026 issuances, Crescent Capital BDC entered into interest rate swaps that convert the fixed-rate obligations on the Tranche A and Tranche B notes into floating-rate exposures based on three-month term SOFR plus respective spreads of 2.5325% and 2.8050%. These swaps, which match the maturities of the underlying notes, are designed to manage the company’s interest rate risk profile and align its liabilities more closely with floating-rate assets.

The most recent analyst rating on (CCAP) stock is a Hold with a $14.50 price target. To see the full list of analyst forecasts on Crescent Capital BDC stock, see the CCAP Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 10, 2026